ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 409,57
-0,15%
Dow Jones
43 828,06
-0,20%
DAX
20 405,92
-0,11%
Brent Oil
74,135
0,00%
Bitcoin
101 832,47
0,37%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Photocure Asa (0IMT)

  7. Photocure Asa (0IMT) Actualités

0IMT

Photocure Asa (0IMT)

Photocure Asa
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0IMT
DateHeureSourceTitreSymboleSociété
09/08/202308h30PR Newswire (US)Photocure ASA: Results for the second quarter and first half of 2023LSE:0IMTPhotocure Asa
06/07/202310h57PR Newswire (US)Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in ChinaLSE:0IMTPhotocure Asa
10/05/202308h18PR Newswire (US)Photocure ASA: Results for the first quarter of 2023LSE:0IMTPhotocure Asa
04/05/202313h48PR Newswire (US)Photocure ASA - Correction: Annual general meeting heldLSE:0IMTPhotocure Asa
03/05/202318h58PR Newswire (US)Photocure ASA - Annual general meeting heldLSE:0IMTPhotocure Asa
03/05/202311h53PR Newswire (US)Photocure ASA: Invitation to presentation of first quarter 2023 financial resultsLSE:0IMTPhotocure Asa
02/05/202317h35PR Newswire (US)Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light CystoscopyLSE:0IMTPhotocure Asa
12/04/202316h14PR Newswire (US)Photocure ASA: Annual Report 2022LSE:0IMTPhotocure Asa
12/04/202316h14PR Newswire (US)Photocure ASA - Notice of the Annual General Meeting 3 May 2023LSE:0IMTPhotocure Asa
14/03/202308h53PR Newswire (US)Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancerLSE:0IMTPhotocure Asa
23/02/202308h29PR Newswire (US)Photocure ASA: Results for the fourth quarter of 2022LSE:0IMTPhotocure Asa
20/02/202307h43PR Newswire (US)Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLCLSE:0IMTPhotocure Asa
03/01/202307h47PR Newswire (US)New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursementLSE:0IMTPhotocure Asa
05/12/202208h08PR Newswire (US)New Evidence: Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO MeetingLSE:0IMTPhotocure Asa
07/11/202208h11PR Newswire (US)Photocure: CMS improves Medicare reimbursement for Blue Light Cystoscopy with Cysview and expands access in the surveillance settingLSE:0IMTPhotocure Asa
02/11/202208h38PR Newswire (US)Photocure ASA: Results for the third quarter of 2022LSE:0IMTPhotocure Asa
04/10/202207h52PR Newswire (US)Data presented at the International Bladder Cancer Network (IBCN) meeting demonstrate a reduction in the risk of recurrence with the use of BLCLSE:0IMTPhotocure Asa
28/09/202208h13PR Newswire (US)Photocure Announces the Commercial Availability of Karl Storz's New Blue Light System in the U.S.LSE:0IMTPhotocure Asa
20/09/202207h54PR Newswire (US)New study demonstrates that tumor removal in the outpatient setting is as good as TURBT under general anesthesiaLSE:0IMTPhotocure Asa
08/09/202207h44PR Newswire (US)Bladder Cancer technology: New KARL STORZ Blue Light Cystoscopy system featured during E-Masterclass in UrologyLSE:0IMTPhotocure Asa
01/09/202208h20PR Newswire (US)Photocure appoints Anders Neijber, MD, PhD as Chief Medical Officer, Global Medical Affairs and Clinical DevelopmentLSE:0IMTPhotocure Asa
10/08/202208h18PR Newswire (US)Photocure ASA: Results for the second quarter of 2022LSE:0IMTPhotocure Asa
09/08/202210h47PR Newswire (US)Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical TrialLSE:0IMTPhotocure Asa
04/08/202215h15PR Newswire (US)Photocure ASA: Invitation to presentation of second quarter and first half year 2022 financial resultsLSE:0IMTPhotocure Asa
05/07/202207h41PR Newswire (US)Photocure Collaborations at EAU Support the Latest Advancements in Bladder Cancer TechnologyLSE:0IMTPhotocure Asa
13/06/202207h50PR Newswire (US)Positive Data from the Danish National Patient Registry presented at the 2022 Nordic Urologisk Forening (NUF) Congress in HelsinkiLSE:0IMTPhotocure Asa
18/05/202207h46PR Newswire (US)Blue Light Cystoscopy continues to make news at AUA 2022LSE:0IMTPhotocure Asa
11/05/202208h18PR Newswire (US)Photocure ASA: Results for the first quarter of 2022LSE:0IMTPhotocure Asa
29/03/202217h14PR Newswire (US)Photocure to Participate in Two Investor Conferences in April: DNB Small & Medium Enterprises and Needham HealthcareLSE:0IMTPhotocure Asa
11/03/202208h59PR Newswire (US)Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in ChinaLSE:0IMTPhotocure Asa
 Showing the most relevant articles for your search:LSE:0IMT

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
SGO
Cie de SaintGobain
EU
MC
Lvmh Moet Hennessy Louis...
SPI
SP500
S&P 500
EU
AI
Air Liquide
EU
CS
Axa
EU
ACA
Credit Agricole
EU
BNP
BNP Paribas
EU
ORA
Orange
COIN
XRPUSD
Ripple
EU
DG
Vinci
EU
AF
Air FranceKLM
COIN
BTCUSD
Bitcoin
EU
ML
Michelin
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés